郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价BAY60-6583 acts as a partial agonist at adenosine A2B receptors.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2014作者：Sonja Hinz; Svenja K Lacher; Benjamin F Seibt; Christa E Müller
阅读更多 →

药效评价FR-190997, a nonpeptide bradykinin B2-receptor partial agonist, is a potent and efficacious intraocular pressure lowering agent in ocular hypertensive cynomolgus monkeys.

期刊：Drug development research发表年份：2014作者：Najam A Sharif; Parvaneh Katoli; Daniel Scott; Linya Li; Curtis Kelly; Shouxi Xu; Shahid Husain; Carol Toris; Craig Crosson
阅读更多 →

药效评价A novel class of succinimide-derived negative allosteric modulators of metabotropic glutamate receptor subtype 1 provides insight into a disconnect in activity between the rat and human receptors.

期刊：ACS chemical neuroscience发表年份：2014作者：Hyekyung P Cho; Darren W Engers; Daryl F Venable; Colleen M Niswender; Craig W Lindsley; P Jeffrey Conn; Kyle A Emmitte; Alice L Rodriguez
阅读更多 →

药效评价Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.

期刊：Molecular pharmacology发表年份：2014作者：Douglas A Schober; Carrie H Croy; Hongling Xiao; Arthur Christopoulos; Christian C Felder
阅读更多 →